{"id":"https://openalex.org/W2021393975","doi":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","title":"The INFUSE-Morphine Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneously Administered Morphine in Patients with Advanced Illness","display_name":"The INFUSE-Morphine Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneously Administered Morphine in Patients with Advanced Illness","publication_year":2009,"publication_date":"2009-10-13","ids":{"openalex":"https://openalex.org/W2021393975","doi":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","mag":"2021393975","pmid":"https://pubmed.ncbi.nlm.nih.gov/19819665"},"language":"en","primary_location":{"id":"doi:10.1016/j.jpainsymman.2009.03.009","doi":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","pdf_url":"http://www.jpsmjournal.com/article/S0885392409007271/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jpsmjournal.com/article/S0885392409007271/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103329944","display_name":"Jay R. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jay R. Thomas","raw_affiliation_strings":["Department of Supportive Care Medicine, City of Hope, Duarte, California 91010-3000, USA. jaythomas@coh.org","Department of Supportive Care Medicine; City of Hope; Duarte California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Supportive Care Medicine, City of Hope, Duarte, California 91010-3000, USA. jaythomas@coh.org","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]},{"raw_affiliation_string":"Department of Supportive Care Medicine; City of Hope; Duarte California USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101705774","display_name":"Mark S. Wallace","orcid":"https://orcid.org/0000-0001-5647-6233","observed_orcids":["https://orcid.org/0000-0001-5647-6233"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark S. Wallace","raw_affiliation_strings":["Department of Anesthesiology, University of California, San Diego Center for Pain Medicine, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, University of California, San Diego Center for Pain Medicine, San Diego, California, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051303665","display_name":"Richard C. Yocum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267878","display_name":"Rockwell Medical, Inc. (United States)","ror":"https://ror.org/04ts35329","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267878"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard C. Yocum","raw_affiliation_strings":["Department of Drug Development and Medical Affairs, Rockwell Medical Technologies, Inc., Wixom, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Development and Medical Affairs, Rockwell Medical Technologies, Inc., Wixom, Michigan, USA","institution_ids":["https://openalex.org/I4405267878"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109281700","display_name":"Daniel E. Vaughn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E. Vaughn","raw_affiliation_strings":["Department of Research and Development, Halozyme Therapeutics, Inc., San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research and Development, Halozyme Therapeutics, Inc., San Diego, California, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028564352","display_name":"Michael F. Haller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael F. Haller","raw_affiliation_strings":["Department of Research and Development, Halozyme Therapeutics, Inc., San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research and Development, Halozyme Therapeutics, Inc., San Diego, California, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112212386","display_name":"Jocelyne Flament","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jocelyne Flament","raw_affiliation_strings":["European Organisation for Research and Treatment of Cancer AISBL-IVZW, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Organisation for Research and Treatment of Cancer AISBL-IVZW, Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5103329944"],"corresponding_institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"],"apc_list":{"value":4760,"currency":"USD","value_usd":4760},"apc_paid":null,"fwci":2.535,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.88354452,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"38","issue":"5","first_page":"663","last_page":"672"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10189","display_name":"Anesthesia and Pain Management","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.8169999718666077},{"id":"https://openalex.org/keywords/recombinant-human-hyaluronidase","display_name":"recombinant human hyaluronidase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/rhuph20","display_name":"rHuPH20","score":0.9860000014305115},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-absorption-enhancement","display_name":"drug absorption enhancement","score":0.7009999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8330000042915344},{"id":"https://openalex.org/keywords/hyaluronic-acid-degradation","display_name":"hyaluronan degradation","score":0.753000020980835},{"id":"https://openalex.org/keywords/intravenous-morphine","display_name":"intravenous morphine","score":0.6629999876022339},{"id":"https://openalex.org/keywords/hospice-care","display_name":"hospice care","score":0.6710000038146973},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.9980000257492065},{"id":"https://openalex.org/keywords/advanced-disease","display_name":"advanced disease","score":0.7870000004768372},{"id":"https://openalex.org/keywords/opioid-analgesia","display_name":"opioid analgesia","score":0.9229999780654907}],"concepts":[{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.8635573387145996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7851911783218384},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6935274600982666},{"id":"https://openalex.org/C2780375986","wikidata":"https://www.wikidata.org/wiki/Q904015","display_name":"Hyaluronidase","level":3,"score":0.6905378699302673},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6475457549095154},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5982874035835266},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5439966917037964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5106492638587952},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4861406981945038},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4587848484516144},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4253726005554199},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3312103748321533},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0760970413684845},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010166","descriptor_name":"Palliative Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jpainsymman.2009.03.009","doi":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","pdf_url":"http://www.jpsmjournal.com/article/S0885392409007271/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},{"id":"pmid:19819665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19819665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pain and symptom management","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/j.jpainsymman.2009.03.009","doi":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jpainsymman.2009.03.009","pdf_url":"http://www.jpsmjournal.com/article/S0885392409007271/pdf","source":{"id":"https://openalex.org/S135898356","display_name":"Journal of Pain and Symptom Management","issn_l":"0885-3924","issn":["0885-3924","1873-6513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pain and Symptom Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320315641","display_name":"Halozyme","ror":"https://ror.org/001x5ea44"},{"id":"https://openalex.org/F4320315955","display_name":"Quest Diagnostics","ror":"https://ror.org/010g9bb70"},{"id":"https://openalex.org/F4320332558","display_name":"Baxter Healthcare Corporation","ror":"https://ror.org/02d6ew870"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2021393975.pdf","grobid_xml":"https://content.openalex.org/works/W2021393975.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1992240399","https://openalex.org/W1994038935","https://openalex.org/W2010209552","https://openalex.org/W2013797651","https://openalex.org/W2017974394","https://openalex.org/W2037558250","https://openalex.org/W2038688257","https://openalex.org/W2059497804","https://openalex.org/W2062102950","https://openalex.org/W2068262067","https://openalex.org/W2092289015","https://openalex.org/W2107448778","https://openalex.org/W2108772427","https://openalex.org/W2110427985","https://openalex.org/W2151495340","https://openalex.org/W2158548553","https://openalex.org/W2162476338"],"related_works":["https://openalex.org/W19819667","https://openalex.org/W2115804062","https://openalex.org/W1999283612","https://openalex.org/W2085260975","https://openalex.org/W7148384611","https://openalex.org/W4255606323","https://openalex.org/W2154106936","https://openalex.org/W205069363","https://openalex.org/W4412885545","https://openalex.org/W2158548553"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}